Contact Information
255 East Watt Street , Alcoa, Tennessee 37701, United States
Detailed Information
Cherokee Health Systems
-
Services:
- Private health insurance
- State-financed health insurance plan other than Medicaid
- Federal military insurance (e.g., TRICARE)
- Medicare
- Cash or self-payment
- Medicaid
- Federal, or any government funding for substance use treatment programs
- SAMHSA funding/block grants
- Treatment for other addiction disorder
- Drug or alcohol urine screening
- STD testing
- Testing for Hepatitis C (HCV)
- Metabolic syndrome monitoring
- TB screening
- HIV testing
- Testing for Hepatitis B (HBV)
- Transportation assistance
- Integrated primary care services
- Case management service
- Mental health services
- Early intervention for HIV
- Prescribes buprenorphine
- Prescribes naltrexone
- Buprenorphine maintenance
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- HIV or AIDS education, counseling, or support
- Health education services other than HIV/AIDS or hepatitis
- Group counseling
- Marital/couples counseling
- Substance use disorder education
- Individual counseling
- Family counseling
- Hepatitis education, counseling, or support
- Smoking/vaping/tobacco cessation counseling
- Federally Qualified Health Center
- State mental health department
- State Substance use treatment agency
- Sliding fee scale (fee is based on income and other factors)
- Naloxone and overdose education
- Aftercare/continuing care
- Clients with co-occurring mental and substance use disorders
- Vaping permitted in designated area
- This facility administers/prescribes medication for alcohol use disorder
- Hepatitis B (HBV) vaccination
- Hepatitis A (HAV) vaccination
- Relapse prevention
- Trauma-related counseling
- Telemedicine/telehealth therapy
- Motivational interviewing
- Substance use disorder counseling
- Anger management
- Cognitive behavioral therapy
- Brief intervention
- Smoking permitted in designated area
- Disulfiram
- Buprenorphine without naloxone
- Naltrexone (extended-release, injectable)
- Non-nicotine smoking/tobacco cessation
- Medication for mental disorders
- Acamprosate (Campral®)
- Nicotine replacement
- Buprenorphine (extended-release, injectable)
- Buprenorphine with naloxone
- Naltrexone (oral)
- Medications for pre-exposure to prophylaxis
- No formal relationship with prescribing entity
- In-network prescribing entity
- Recovery coach
- Mentoring/peer support
- Assistance with obtaining social services
- Housing services
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
- Screening for tobacco use
- Screening for substance use
- Complete medical history/physical exam
- Comprehensive substance use assessment
- Screening for mental disorders
- Comprehensive mental health assessment
- Sign language services for the deaf and hard of hearing
- Female
- Male
- Regular outpatient treatment
- Outpatient
- Outpatient methadone/buprenorphine or naltrexone treatment
- Private non-profit organization
Payment/Insurance/Funding Accepted
Other Services
Testing
Ancillary Services
Type of Opioid Treatment
Opioid Medications used in Treatment
Education and Counseling Services
License/Certification/Accreditation
Payment Assistance Available
Transitional Services
Special Programs/Groups Offered
Facility Vaping Policy
Type of Alcohol Use Disorder Treatment
Medical Services
Treatment Approaches
Facility Smoking Policy
Pharmacotherapies
External Source of Medications Used for Alcohol Use Disorder Treatment
Recovery Support Services
Type of Care
Assessment/Pre-treatment
Language Services
Gender Accepted
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Facility Operation (e.g., Private, Public)
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm